IMBRUVICA ibrutinib 560 mg film-coated tablet blister

Janssen-Cilag Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 0ad88b2d7d81e39c
Product Name: IMBRUVICA ibrutinib 560 mg film-coated tablet blister
Artg Id: 319380
Artg Name: IMBRUVICA ibrutinib 560 mg film-coated tablet blister
Sponsor: Janssen-Cilag Pty Ltd
Company Detail Path: /organization/janssen-cilag-pty-ltd
Artg Date: 2020-08-04
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/9a3567254784aeaafba3fbf97530e391.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/5352b9b8d83317106001f4cb426bab43.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

Dec 9, 2025

Approval ID

0ad88b2d7d81e39c

Type

Standard